Surveyor Capital logo

Surveyor Capital

North America, Illinois, United States, Chicago

Description

Surveyor Capital is an investment firm that focuses on access and opportunity to companies and entrepreneurs.

Investor Profile

Surveyor Capital has made 151 investments, with 13 in the past 12 months and 10% as lead.

Stage Focus

  • Series B (40%)
  • Post Ipo Equity (23%)
  • Series C (18%)
  • Series A (10%)
  • Series Unknown (4%)
  • Series D (3%)
  • Series E (1%)
  • Private Equity (1%)
  • Convertible Note (1%)

Country Focus

  • United States (89%)
  • Switzerland (3%)
  • Canada (2%)
  • United Kingdom (2%)
  • China (1%)
  • Ireland (1%)
  • Germany (1%)
  • Singapore (1%)
  • Denmark (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Biopharma
  • Life Science
  • Oncology
  • Health Diagnostics
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Surveyor Capital frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 19
OrbiMed
North America, New York, United States, New York
Co-Investments: 35
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 23
CA
North America, Massachusetts, United States, Boston
Co-Investments: 43
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 27
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 21
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 49
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 30
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 57
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 37

Which angels does Surveyor Capital often collaborate with?

SK
North America, California, United States, Los Angeles
Shared Deals: 1
TA
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
RK
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Surveyor Capital?

Arbor Biotechnologies

Cambridge, Massachusetts, United States

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

BiopharmaBiotechnologyLife Science
Series CMar 18, 2025
Amount Raised: $73,900,000
VeraDermics

New Haven, Connecticut, United States

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts.

Health CarePharmaceuticalTherapeutics
Series BDec 11, 2024
Amount Raised: $75,000,000
35Pharma

Montreal, Quebec, Canada

35Pharma is a biopharmaceutical company that designs and develops innovative biologics for diseases of high unmet medical need.

BiopharmaBiotechnologyPharmaceutical
Series CNov 26, 2024
Amount Raised: $53,000,000
ADCendo

Copenhagen, Hovedstaden, Denmark

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

BiotechnologyHealth Care
Series BNov 25, 2024
Amount Raised: $135,000,000
Avenzo Therapeutics

San Diego, California, United States

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series ANov 18, 2024
OnKure Therapeutics

Boulder, Colorado, United States

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

BiotechnologyLife SciencePrecision MedicineTherapeutics
Post Ipo EquityOct 4, 2024
Amount Raised: $65,000,000
Outpace Bio

Seattle, Washington, United States

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

BiotechnologyHealth CareLife SciencePharmaceutical
Series BAug 1, 2024
Amount Raised: $144,000,000
Scorpion Therapeutics

Boston, Massachusetts, United States

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

BiotechnologyHealth CareLife ScienceOncologyPrecision Medicine
Series CJul 16, 2024
Amount Raised: $150,000,000
Cartesian Therapeutics

Gaithersburg, Maryland, United States

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

BiotechnologyOncology
Post Ipo EquityJul 2, 2024
Amount Raised: $130,000,000
Marea Therapeutics

San Francisco, California, United States

Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.

BiotechnologyGeneticsLife Science
Series BJun 18, 2024
Amount Raised: $190,000,000